Why Aurora Cannabis Inc.’s (ACB) Stock Is Up 13.14%
As of Monday, October 05, Aurora Cannabis Inc.’s ACB share price has surged by 13.14%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty’s, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Commentary & Analysis
Why Aurora Cannabis Inc.’s (ACB) Stock Is Up 15.82%
As of Monday, October 05, Aurora Cannabis Inc.’s ACB share price has surged by 15.82%, which has investors questioning if this is right time to sell.Jenna Brashear
4 Undervalued Pharmaceuticals Stocks for Tuesday, September 29
Discover the top 4 undervalued Pharmaceuticals stocks for Tuesday, September 29 based on AAII’s Stock Grades.Rosalio Madrigal
Why Aurora Cannabis Inc.’s (ACB) Stock Is Up 5.45%
As of Wednesday, August 12, Aurora Cannabis Inc.’s ACB share price has surged by 5.45%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Aurora Cannabis Inc.’s (ACB) Stock Is Up 13.49%
As of Tuesday, August 11, Aurora Cannabis Inc.’s ACB share price has surged by 13.49%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | ACB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $295.8 | $519.2 | 32% |
|
| Shares Out (Mil) | 43.5 | 42.8 | 44% |
|
| Institutional Ownership | 93.2% | 82.8% | 62% |
|
| Float (Mil) | 65.3 | 44.4 | 52% |
|
| Beta | 1.42 | 0.71 | 80% |
|
| Avg Daily Volume (000s) | 1,439 | 394 | 76% |
|
| Price Change (52-week) |
(26.4%) | 60.2% | 32% |
|
| Growth | ACB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 3.0% | 6.1% | 28% |
|
| Net Income (5yr) | 29.5% | (2.0%) | 84% |
|
| EPS (5yr) | 44.7% | 15.0% | 91 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.8%) | (15.1%) | 47% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ACB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $221 | $416 | 33% |
|
| Net Income (TTM) (Mil) | ($85) | ($11) | 12% |
|
| EPS (TTM) | ($1.457) | ($0.700) | 18% |
|
| Operating Cash Flow (TTM) (Mil) | ($20) | ($7) | 15% |
|
| Net Cash Flow (TTM) (Mil) | ($51) | $6 | 20% |
|
| Long-Term Debt (Q1) (Mil) | $12 | $6 | 29% |
|
| Enterprise Value (Q1) (Mil) | $240 | $494 | 27% |
|
| Valuation | ACB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.77 | 2.31 | 16% |
|
| P/E | na | 17.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | ACB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 44.2% | 69.4% | 55% |
|
| Net Margin | (38.2%) | 3.2% | 13% |
|
| ROA | (16.1%) | (22.2%) | 22% |
|
| ROE | (21.8%) | (21.4%) | 23% |
|
| Liabilities to Assets | 15.1% | 32.8% | 9% |
|
| F-Score | 4 | 3 | 33% |
|
Aurora Cannabis Inc. did not pass any screens on 10/9/2026.
